Last reviewed · How we verify
NCT06883838: CASCADE
Project CASCADE: Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement
NA trial testing Survivorship care delivery intervention in Cancer Survivorship in 5,584 participants. Enrolling by invitation.
31 May 2029
Quick facts
| Lead sponsor | The University of Texas Health Science Center, Houston |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 5,584 |
| Start date | 1 September 2025 |
| Primary completion | 31 May 2029 |
| Estimated completion | 31 May 2029 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Survivorship care delivery intervention
Conditions studied
- Cancer Survivorship — all drugs for Cancer Survivorship →
Sponsor
The University of Texas Health Science Center, Houston
Who can join
18 and older, any sex, with Cancer Survivorship. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to implement a clinic-level cancer survivorship care delivery intervention in partnership with community health center clinicians, patients, and community representatives to test effectiveness of the intervention to improve patient and clinician outcomes and to evaluate implementation of the intervention using an iterative, concurrent mixed-methods approach guided by the Practice Change Model.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement (Project CASCADE): a study protocol for a pragmatic, stepped-wedge, cluster-randomized trial in Texas primary care community health centers.
Millett ME, Malthaner LQ, McCallister K, Craig DW, et al · · 2025 · PMID 41454266 · DOI 10.1186/s12875-025-03108-1
Verify or expand the search:
- PubMed search for NCT06883838
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer Survivorship
Currently open trials in the same condition.
- NCT07332377 — mHealth Intervention for Pain Self Management · NA · recruiting
- NCT06848491 — Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors · NA · recruiting
- NCT06623097 — Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study · NA · recruiting
- NCT06840028 — Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Can · NA · recruiting
- NCT06869512 — Cooperative Extension and Cancer Survivorship · NA · recruiting
Other The University of Texas Health Science Center, Houston trials
Trials by the same sponsor.
- NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
- NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
- NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
- NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
- NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06883838 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
- Last refreshed: 9 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06883838.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing